CA
NZ
UK
AU
IND
US
● No new company announcement accompanied the rebound.
● No new company news accompanied the advance.
● The gain came ahead of the company's own third-quarter report.
● Revenue returned to growth and losses narrowed in the latest results.
● Gene therapy data for Rett syndrome took the stage at a medical conference in Hamburg.
● The rally came on heavy trading volume without a clear company catalyst.
● No fresh company announcement accompanied the rally.
● No new disclosure accompanied the gain in volatile biotech trade.
● No fresh company announcement accompanied the retreat.
Glaukos Corporation (NYSE:GKOS) shares jumped in pre-market trading after a third-quarter report that cleared estimates on both revenue and profit. Net sales rose 58% from a year earlier, and the adjusted profit replaced the loss the market had pencilled in.
Please wait processing your request...